Drug intelligence / Profile preview

betamethasone

Development stage
Approved
Lead developer
Merck
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Topical, Oral, Intramuscular, Intravenous, Ophthalmic
01

Overview

Betamethasone is a synthetic long-acting corticosteroid with potent glucocorticoid activity and negligible mineralocorticoid effects. It acts as an agonist of the glucocorticoid receptor to exert anti-inflammatory and immunosuppressive actions. The drug is used in various formulations (topical creams/ointments/lotions/gels/foams/sprays; oral solution; injectable suspension) to treat a wide range of conditions including inflammatory skin diseases (such as eczema and psoriasis), allergic reactions, rheumatic disorders (like rheumatoid arthritis and systemic lupus erythematosus), endocrine disorders (including adrenal insufficiency), gastrointestinal diseases, hematologic disorders, neoplastic diseases, ophthalmic diseases, renal diseases, respiratory conditions (such as asthma), nervous system disorders (including cerebral edema), and for stimulating fetal lung maturation in preterm labor. Its mechanism involves both genomic pathways—modulating gene expression to promote anti-inflammatory proteins—and nongenomic pathways that rapidly modulate immune cell activity[1][4][5][6].

Brand names
AlphatrexBeta-ValBetadermBetanateBetatrexCelestoneCelestone SoluspanBetaject
Other names
betamethasone dipropionatebetamethasone valerate
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on betamethasone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on betamethasone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call